Certara Inc
CERT11.480USD
-0.310-2.63%
Close 09/19, 16:00（ET）Quotes delayed by 15 min
1.84BMarket Cap
231.03P/E TTM
More Details of Certara Inc Company
Certara, Inc. is engaged in model-informed drug development. The Company accelerates medicine using biosimulation software, technology and services to transform traditional drug discovery and development. It delivers software products and technology-driven services to customers to efficiently carry out and realize the full benefits of biosimulation in drug discovery, preclinical and clinical research, regulatory submissions and market access. Its regulatory science and market access software and services are underpinned by technologies such as regulatory submissions software, natural language processing and Bayesian analytics. It also develops scientific informatics software products used by the life sciences industry for in-silico research. It develops advanced modeling and biosimulation solutions used to predict the pharmacokinetic and pharmacodynamic properties. Its clients include 2,400 biopharmaceutical companies, academic institutions and regulatory agencies across 66 countries.
Company Info
Ticker SymbolCERT
Company nameCertara Inc
IPO dateDec 11, 2020
CEODr. William F. (Bill) Feehery, Ph.D.
Number of employees1487
Security typeOrdinary Share
Fiscal year-endDec 11
Address4 Radnor Corporate Center, Suite 350
CityRADNOR
Stock exchangeNASDAQ Global Select Consolidated
CountryUnited States of America
Postal code19087
Phone14152378272
Websitehttps://www.certara.com/
Ticker SymbolCERT
IPO dateDec 11, 2020
CEODr. William F. (Bill) Feehery, Ph.D.
Company Executives
Name
Name/Position
Position
Shareholding
Change
Mr. John E. Gallagher, III
Mr. John E. Gallagher, III
Chief Financial Officer, Senior Vice President
Chief Financial Officer, Senior Vice President
89.01K
+46.64%
Mr. Stephen M. Mclean
Mr. Stephen M. Mclean
Independent Director
Independent Director
42.00K
--
Ms. Nancy Killefer
Ms. Nancy Killefer
Independent Director
Independent Director
36.09K
+49.37%
Mr. Eran Broshy
Mr. Eran Broshy
Independent Director
Independent Director
34.95K
+51.81%
Ms. Rosemary A. (Rose) Crane
Ms. Rosemary A. (Rose) Crane
Independent Director
Independent Director
29.91K
+66.31%
Ms. Rona Anhalt
Ms. Rona Anhalt
Chief Human Resources Officer
Chief Human Resources Officer
5.18K
--
Mr. Adrian Mckemey, Ph.D.
Mr. Adrian Mckemey, Ph.D.
President - Certara Drug Development Solutions
President - Certara Drug Development Solutions
--
--
Dr. William F. (Bill) Feehery, Ph.D.
Dr. William F. (Bill) Feehery, Ph.D.
Chief Executive Officer, Director
Chief Executive Officer, Director
--
--
Mr. Matthew Walsh
Mr. Matthew Walsh
Independent Director
Independent Director
--
--
Ms. Cynthia L. Collins
Ms. Cynthia L. Collins
Independent Director
Independent Director
--
--
View more
Name
Name/Position
Position
Shareholding
Change
Mr. John E. Gallagher, III
Mr. John E. Gallagher, III
Chief Financial Officer, Senior Vice President
Chief Financial Officer, Senior Vice President
89.01K
+46.64%
Mr. Stephen M. Mclean
Mr. Stephen M. Mclean
Independent Director
Independent Director
42.00K
--
Ms. Nancy Killefer
Ms. Nancy Killefer
Independent Director
Independent Director
36.09K
+49.37%
Mr. Eran Broshy
Mr. Eran Broshy
Independent Director
Independent Director
34.95K
+51.81%
Ms. Rosemary A. (Rose) Crane
Ms. Rosemary A. (Rose) Crane
Independent Director
Independent Director
29.91K
+66.31%
Ms. Rona Anhalt
Ms. Rona Anhalt
Chief Human Resources Officer
Chief Human Resources Officer
5.18K
--
Revenue Breakdown
Currency: USDUpdated: Sun, Jul 6
Currency: USDUpdated: Sun, Jul 6
FY2025Q1
FY2024
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022
FY2022Q4
FY2022Q3
FY2022Q2
FY2021
FY2020
FY2019
No Data
By RegionUSD
Name
Revenue
Proportion
Americas
71.95M
67.88%
EMEA
25.79M
24.33%
Asia Pac
8.26M
7.79%
By Business
By Region
No Data
Shareholding Stats
Updated: Fri, Sep 5
Updated: Fri, Sep 5
Shareholders
Shareholder Types
Shareholders
Shareholders
Proportion
Arsenal Capital Management LP
22.63%
Wasatch Global Investors Inc
8.43%
The Vanguard Group, Inc.
7.72%
BlackRock Institutional Trust Company, N.A.
7.66%
ArrowMark Colorado Holdings, LLC
4.91%
Other
48.66%
Shareholders
Shareholders
Proportion
Arsenal Capital Management LP
22.63%
Wasatch Global Investors Inc
8.43%
The Vanguard Group, Inc.
7.72%
BlackRock Institutional Trust Company, N.A.
7.66%
ArrowMark Colorado Holdings, LLC
4.91%
Other
48.66%
Shareholder Types
Shareholders
Proportion
Investment Advisor/Hedge Fund
36.33%
Investment Advisor
30.75%
Private Equity
22.63%
Hedge Fund
5.99%
Pension Fund
4.78%
Individual Investor
2.60%
Bank and Trust
2.56%
Research Firm
1.03%
Sovereign Wealth Fund
0.06%
Institutional Shareholding
Updated: Tue, Jul 1
Updated: Tue, Jul 1
Reporting Period
No. of institutions
Shares Held
Proportion
Change
2025Q2
555
167.47M
104.26%
-28.99M
2025Q1
581
167.89M
103.79%
-30.27M
2024Q4
555
159.66M
99.16%
-26.90M
2024Q3
552
158.15M
98.27%
-50.95M
2024Q2
541
163.64M
101.70%
-44.53M
2024Q1
534
163.75M
102.11%
-41.24M
2023Q4
526
163.00M
102.00%
-14.84M
2023Q3
527
164.29M
102.80%
-13.35M
2023Q2
514
163.33M
102.24%
-11.18M
2023Q1
493
163.67M
102.43%
+4.75M
View more
Shareholder Activity
Name
Shares Held
Proportion
Change
Chg %
Date
Arsenal Capital Management LP
36.35M
22.4%
--
--
Apr 14, 2025
Wasatch Global Investors Inc
9.29M
5.73%
+352.65K
+3.95%
Mar 31, 2025
The Vanguard Group, Inc.
12.42M
7.65%
+3.49K
+0.03%
Mar 31, 2025
BlackRock Institutional Trust Company, N.A.
12.27M
7.56%
-478.39K
-3.75%
Mar 31, 2025
ArrowMark Colorado Holdings, LLC
7.50M
4.62%
+1.29M
+20.74%
Mar 31, 2025
Dimensional Fund Advisors, L.P.
7.92M
4.88%
+46.14K
+0.59%
Mar 31, 2025
Geneva Capital Management LLC
5.67M
3.5%
+213.09K
+3.90%
Mar 31, 2025
Teacher Retirement System of Texas
4.53M
2.79%
-29.02K
-0.64%
Mar 31, 2025
Columbia Threadneedle Investments (UK)
4.01M
2.47%
+491.27K
+13.98%
Mar 31, 2025
Deerfield Management Company, L.P.
2.02M
1.25%
+2.02M
--
Mar 31, 2025
View more
Related ETFs
Updated: Sat, Sep 6
Updated: Sat, Sep 6
Name
Proportion
KraneShares Man Buyout Beta Index ETF
0.13%
SPDR S&P SmallCap 600 ESG ETF
0.11%
Proshares Ultra Smallcap 600
0.08%
Innovator US Small Cap Managed Floor ETF
0.07%
JPMorgan Carbon Transition US Equity ETF
0.01%
Harbor Long-Short Equity ETF
0%
First Trust Multicap Growth Alphadex Fund
0%
First Trust Health Care Alphadex Fund
0%
SPDR S&P 600 Small Cap Value ETF
0%
iShares U.S. Healthcare Providers ETF
0%
View more
KraneShares Man Buyout Beta Index ETF
Proportion0.13%
SPDR S&P SmallCap 600 ESG ETF
Proportion0.11%
Proshares Ultra Smallcap 600
Proportion0.08%
Innovator US Small Cap Managed Floor ETF
Proportion0.07%
JPMorgan Carbon Transition US Equity ETF
Proportion0.01%
Harbor Long-Short Equity ETF
Proportion0%
First Trust Multicap Growth Alphadex Fund
Proportion0%
First Trust Health Care Alphadex Fund
Proportion0%
SPDR S&P 600 Small Cap Value ETF
Proportion0%
iShares U.S. Healthcare Providers ETF
Proportion0%
Dividend
A total of
0.00
USD has been distributed in dividends over the past 5 years.
Date
Dividend
Record Date
Payment Date
Ex-dividend Date
No Data
Stock Split
Date
Type
Ratio
No Data
Date
Type
Ratio
No Data
